Kelly Chibale

4.3k total citations
99 papers, 2.7k citations indexed

About

Kelly Chibale is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kelly Chibale has authored 99 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Organic Chemistry, 36 papers in Molecular Biology and 34 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kelly Chibale's work include Malaria Research and Control (26 papers), Computational Drug Discovery Methods (17 papers) and Research on Leishmaniasis Studies (16 papers). Kelly Chibale is often cited by papers focused on Malaria Research and Control (26 papers), Computational Drug Discovery Methods (17 papers) and Research on Leishmaniasis Studies (16 papers). Kelly Chibale collaborates with scholars based in South Africa, United States and United Kingdom. Kelly Chibale's co-authors include Gregory S. Smith, Jiří Gut, Philip J. Rosenthal, Carmen De Kock, Peter J. Smith, Prinessa Chellan, Stuart Warren, Aman Mahajan, Vipan Kumar and Catherine S. Adamson and has published in prestigious journals such as Nature, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Kelly Chibale

95 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Chibale South Africa 31 1.5k 815 610 447 391 99 2.7k
Elisabeth Davioud–Charvet France 35 1.4k 1.0× 1.3k 1.6× 1.1k 1.8× 396 0.9× 275 0.7× 102 3.5k
Diogo Rodrigo Magalhães Moreira Brazil 35 1.9k 1.3× 875 1.1× 833 1.4× 457 1.0× 253 0.6× 103 3.2k
Nicoletta Basilico Italy 35 1.2k 0.8× 880 1.1× 1.5k 2.4× 288 0.6× 420 1.1× 142 3.6k
Sankaranarayanan Murugesan India 32 1.7k 1.1× 1.1k 1.4× 257 0.4× 334 0.7× 449 1.1× 204 3.4k
Christian D. Klein Germany 37 1.3k 0.9× 1.7k 2.0× 1.5k 2.4× 411 0.9× 422 1.1× 101 4.5k
Prem M. S. Chauhan India 41 3.5k 2.4× 1.1k 1.4× 701 1.1× 259 0.6× 252 0.6× 145 4.5k
Núbia Boechat Brazil 29 2.0k 1.4× 737 0.9× 514 0.8× 125 0.3× 213 0.5× 140 2.9k
Kumkum Srivastava India 37 2.2k 1.5× 956 1.2× 914 1.5× 160 0.4× 477 1.2× 96 3.3k
Ana Cristina Lima Leite Brazil 32 2.1k 1.4× 1.0k 1.2× 752 1.2× 342 0.8× 229 0.6× 134 3.5k
Dana E. Vanderwall United States 20 599 0.4× 1.3k 1.6× 459 0.8× 399 0.9× 367 0.9× 28 2.2k

Countries citing papers authored by Kelly Chibale

Since Specialization
Citations

This map shows the geographic impact of Kelly Chibale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Chibale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Chibale more than expected).

Fields of papers citing papers by Kelly Chibale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Chibale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Chibale. The network helps show where Kelly Chibale may publish in the future.

Co-authorship network of co-authors of Kelly Chibale

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Chibale. A scholar is included among the top collaborators of Kelly Chibale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Chibale. Kelly Chibale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Veale, Clinton G. L., et al.. (2025). Chemistry as a Catalyst for Transforming the Health and Wealth of South Africa. Angewandte Chemie International Edition. 64(12). e202419681–e202419681. 1 indexed citations
3.
Chibale, Kelly, et al.. (2024). Model‐Informed Approaches to Optimizing Therapeutics in the African Patient Populations. Clinical Pharmacology & Therapeutics. 116(6). 1391–1394. 1 indexed citations
4.
Reader, Janette, Mariëtte van der Watt, Jandeli Niemand, et al.. (2024). Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials. Nature Communications. 15(1). 9896–9896. 2 indexed citations
5.
Herrmann, Lars, Lucie Paloque, Godwin Akpeko Dziwornu, et al.. (2024). Characterization of antimalarial activity of artemisinin-based hybrid drugs. Antimicrobial Agents and Chemotherapy. 68(7). e0014324–e0014324. 2 indexed citations
6.
Chibale, Kelly, et al.. (2023). Developing kinase inhibitors for malaria: an opportunity or liability?. Trends in Parasitology. 39(9). 720–731. 4 indexed citations
7.
Hikaambo, Christabel Nang’andu, et al.. (2023). Drug discovery in Africa tackles zoonotic and related infections. Science Translational Medicine. 15(718). eadj0035–eadj0035.
8.
Turón, Gemma, et al.. (2023). First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa. Nature Communications. 14(1). 5736–5736. 38 indexed citations
9.
Singh, Vinayak, Godwin Akpeko Dziwornu, & Kelly Chibale. (2023). The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics. Nature Reviews Chemistry. 7(5). 340–354. 12 indexed citations
10.
Kanai, Mariko, et al.. (2022). Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment. Trends in Parasitology. 38(9). 711–718. 3 indexed citations
11.
Singh, Vinayak, Elizabeth Kigondu, Pooja Agarwal, et al.. (2021). Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 65(5). 20 indexed citations
12.
Adamson, Catherine S., Kelly Chibale, Rebecca J. M. Goss, et al.. (2021). Antiviral drug discovery: preparing for the next pandemic. Chemical Society Reviews. 50(6). 3647–3655. 167 indexed citations
13.
Coertzen, Dina, Janette Reader, Mariëtte van der Watt, et al.. (2021). Exploring the transmission-blocking activity of antiplasmodial 3,6-diarylated imidazopyridazines. Transactions of the Royal Society of South Africa. 76(3). 225–233. 1 indexed citations
14.
Aggarwal, Varinder K., Susan K. Armstrong, Lorenzo Caggiano, et al.. (2020). Stuart Warren (24 Dec 1938–22 Mar 2020). Organic & Biomolecular Chemistry. 18(37). 7236–7237. 1 indexed citations
15.
Eyermann, Charles J., Lauren B. Arendse, Gregory S. Basarab, et al.. (2020). Structural Basis for Inhibitor Potency and Selectivity of Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors. ACS Infectious Diseases. 6(11). 3048–3063. 21 indexed citations
16.
Geary, Timothy G., et al.. (2012). A new approach for anthelmintic discovery for humans. Trends in Parasitology. 28(5). 176–181. 26 indexed citations
17.
Chellan, Prinessa, et al.. (2011). Synthesis and in vitro evaluation of palladium(II) salicylaldiminato thiosemicarbazone complexes against Trichomonas vaginalis. Journal of Inorganic Biochemistry. 105(12). 1562–1568. 36 indexed citations
18.
Singh, Kamaljit, Kawaljit Singh, Kawaljit Singh, et al.. (2011). Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity. European Journal of Medicinal Chemistry. 46(6). 2290–2294. 66 indexed citations
19.
Biot, Christophe & Kelly Chibale. (2006). Novel Approaches to Antimalarial Drug Discovery. Infectious Disorders - Drug Targets. 6(2). 173–204. 54 indexed citations
20.
Chibale, Kelly. (2005). Economic drug discovery and rational medicinal chemistry for tropical diseases. Pure and Applied Chemistry. 77(11). 1957–1964. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026